Abstract:Deletion of SIRT1 in hepatocytes enhances NLRP3 signaling and triggers HSC activation and liver fibrosis in young mice in response to liver injury. Unlike young mice, age‐dependent defect of hepatic SIRT1 drives NLRP3 activation and inflammation, which amplifies the initial insult and creates a vicious circle that impairs the capability to resolve fibrosis in old mice even after injury cessation. NLRP3 inhibition by MCC950 ameliorates age‐ and alcohol‐induced liver fibrosis likely by reducing inflammatory cell infiltration and suppressing hepatocyte‐derived danger signaling. Our studies indicate that the longevity factor SIRT1 is implicated in metabolic disease; however, whether and how hepatocyte‐specific SIRT1 signaling is involved in liver fibrosis remains undefined. We characterized a functional link of age‐mediated defects in SIRT1 to the NLRP3 inflammasome during age‐related liver fibrosis. In multiple experimental murine models of liver fibrosis, we compared the development of liver fibrosis in young and old mice, as well as in liver‐specific SIRT1 knockout (SIRT1 LKO) mice and wild‐type (WT) mice. Liver injury, fibrosis, and inflammation were assessed histologically and quantified by real‐time PCR analysis. In a model of hepatotoxin‐induced liver fibrosis, old mice displayed more severe and persistent liver fibrosis than young mice during liver injury and after injury cessation, as characterized by inhibition of SIRT1, induction of NLRP3, infiltration of macrophages and neutrophils, activation of hepatic stellate cells (HSCs), and excessive deposition and remodeling of the extracellular matrix. Mechanistically, deletion of SIRT1 in hepatocytes resulted in NLRP3 and IL‐1β induction, pro‐inflammatory response, and severe liver fibrosis in young mice, mimicking the ability of aging to impair the resolution of established fibrosis. In an aging mouse model, chronic‐plus‐binge alcohol feeding‐induced liver fibrosis was attenuated by treatment with MCC950, a selective NLRP3 inhibitor. NLRP3 inhibition ameliorated alcoholic liver fibrosis in old mice by repressing inflammation and reducing hepatocyte‐derived danger signaling—ASK1 and HMGB1. In conclusion, age‐dependent SIRT1 defects lead to NLRP3 activation and inflammation, which in turn impairs the capacity to resolve fibrosis during aging.

NLR Family Pyrin Domain‐Containing 3 Inflammasome Activation in Hepatic Stellate Cells Induces Liver Fibrosis in Mice

NLRP3 inflammasome driven liver injury and fibrosis: Roles of IL‐17 and TNF in mice

NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice

NOD‐like receptor protein 3 activation causes spontaneous inflammation and fibrosis that mimics human NASH

NLRP3 inflammasome in hepatic diseases: A pharmacological target

Palmitic Acid Stimulates NLRP3 Inflammasome Activation Through TLR4-NF-κB Signal Pathway in Hepatic Stellate Cells

Inflammasomes in Liver Fibrosis

Role of NLR family pyrin domain-containing 3 inflammasome in the activation of pancreatic stellate cells

NLRP3 Inflammasome Activation from Kupffer Cells is Involved in Liver Fibrosis of Schistosoma Japonicum-Infected Mice Via NF-κB

The Role of NLRP3 Inflammasome Activation Pathway of Hepatic Macrophages in Liver Ischemia–Reperfusion Injury

NLRP3 deficiency did not attenuate NASH development under high fat calorie diet plus high fructose and glucose in drinking water

Inflammasome-mediated regulation of hepatic stellate cells.

The Myeloid Heat Shock Transcription Factor 1/-Catenin Axis Regulates Nlr Family, Pyrin Domain-Containing 3 Inflammasome Activation In Mouse Liver Ischemia/Reperfusion Injury

Potentiation of Hepatic Stellate Cell Activation by Extracellular ATP is Dependent on P2X7R-mediated NLRP3 Inflammasome Activation

The heavy subunit of ferritin stimulates NLRP3 inflammasomes in hepatic stellate cells through ICAM-1 to drive hepatic inflammation

S100A8-Mediated NLRP3 Inflammasome-Dependent Pyroptosis in Macrophages Facilitates Liver Fibrosis Progression

NLRP3 is dispensable for d-galactosamine/lipopolysaccharide-induced acute liver failure

Activation of NLRP3 Inflammasomes in Mouse Hepatic Stellate Cells During Schistosoma J. Infection.

Age‐dependent loss of hepatic SIRT1 enhances NLRP3 inflammasome signaling and impairs capacity for liver fibrosis resolution

Histones Activate the NLRP3 Inflammasome in Kupffer Cells During Sterile Inflammatory Liver Injury

Macrophage Sphingosine 1-Phosphate Receptor 2 Blockade Attenuates Liver Inflammation and Fibrogenesis Triggered by NLRP3 Inflammasome